|
2025
|
P/S
|
Transdermal patches featuring contraceptive preparations, namely, contraceptives in the form of a... |
|
2024
|
Invention
|
Amphetamine carbamate compounds and methods.
Described herein are the amphetamine-related compou... |
|
2023
|
Invention
|
Amphetamine carbamate compounds and methods. Described herein are methods for quantitatively dete... |
|
|
Invention
|
Transdermal amphetamine compositions with low levels of carbamate.
Described are methods for red... |
|
2022
|
Invention
|
Stable transdermal amphetamine compositions and methods of manufacture.
Described are transderma... |
|
|
Invention
|
Transdermal amphetamine compositions with low levels of carbamate. Described are methods for redu... |
|
|
Invention
|
Amphetamine carbamate compounds and methods. Described herein are the amphetamine-related compoun... |
|
2021
|
P/S
|
Pharmaceutical preparations, namely, contraceptives in the form of a transdermal patch |
|
|
Invention
|
Stretchable backing layers for transdermal drug delivery systems.
Stretchable, occlusive backing... |
|
2019
|
Invention
|
Silicone-containing acrylic polymers for transdermal drug delivery compositions. Described herein... |
|
2018
|
Invention
|
Transdermal pharmaceutical compositions with reduced skin irritation.
Described are transdermal ... |
|
|
Invention
|
Transdermal pharmaceutical compositions with reduced skin irritation. Described are transdermal a... |
|
|
Invention
|
Compositions and methods for transdermal delivery of amphetamine.
Compositions for the transderm... |
|
2017
|
Invention
|
Pharmaceutical compositions and methods for delivery of bremelanotide.
Described are topical, tr... |
|
|
Invention
|
Stable transdermal amphetamine compositions and methods of manufacture. Described are transdermal... |
|
|
Invention
|
Transdermal drug delivery systems for norethindrone acetate.
Described are transdermal drug deli... |
|
|
Invention
|
Pressure-sensitive adhesives for transdermal drug delivery. Described are pressure-sensitive adhe... |
|
2016
|
Invention
|
Gastric acid modulators for oral delivery of peptides and proteins.
Described are methods for or... |
|
|
Invention
|
Stretchable backing layers for transdermal drug delivery systems. Stretchable, occlusive backing ... |
|
|
Invention
|
Transdermal drug delivery systems with polyisobutylene face adhesive.
Described are transdermal ... |
|
|
Invention
|
Compositions and methods for transdermal delivery of amphetamine. Compositions for the transderma... |
|
|
Invention
|
Transdermal drug delivery systems for levonorgestrel and ethinyl estradiol.
Described are transd... |
|
|
Invention
|
Transdermal drug delivery systems for levonorgestrel and ethinyl estradiol. Described are transde... |
|
|
Invention
|
Device for transdermal administration of drugs including acrylic based polymers. A transdermal de... |
|
|
Invention
|
Transdermal testosterone device and delivery.
Described are transdermal drug delivery systems fo... |
|
|
Invention
|
Oligomeric/polymeric silicone fluids for use in transdermal drug delivery systems. Described are ... |
|
|
Invention
|
Oligomeric/polymeric silicone fluids for use in transdermal drug delivery systems.
Described are... |
|
|
Invention
|
Multi-polymer compositions for transdermal drug delivery.
Multi-polymer compositions for the tra... |
|
2015
|
Invention
|
Transdermal drug delivery systems for agomelatine. Described are transdermal drug delivery system... |
|
|
Invention
|
Transdermal drug delivery systems for agomelatine.
Described are transdermal drug delivery syste... |
|
|
Invention
|
Compositions and method for sustained drug delivery by active transdermal technology. Described a... |
|
|
Invention
|
Transdermal estrogen device and delivery. Described are transdermal drug delivery systems for the... |
|
|
Invention
|
Transdermal drug delivery device including an occlusive backing. A transdermal drug delivery syst... |
|
|
Invention
|
Microneedle device and methods. Described are microneedle devices comprising an electron beam cro... |
|
|
Invention
|
Silicone-containing acrylic polymers for transdermal drug delivery compositions.
Described herei... |
|
2013
|
P/S
|
Pharmaceutical preparations for use in the treatment, alleviation and prevention of moderate to s... |
|
2011
|
P/S
|
Pharmaceutical preparations for use in the treatment [ of gynecological disorders and conditions,... |
|
1999
|
P/S
|
pharmaceutical preparations, namely, transdermal and transmucosal delivery systems in the nature ... |
|
1997
|
P/S
|
pharmaceutical preparation for hormone therapy containing at least one estrogen and at least one ... |
|
1989
|
P/S
|
TRANSDERMALLY - DELIVERED HORMONAL THERAPY |
